Literature DB >> 15282304

A histone methyltransferase is required for maximal response to female sex hormones.

Tobias Carling1, Keun-Cheol Kim, Xiao-Hong Yang, Jian Gu, Xiao-Kun Zhang, Shi Huang.   

Abstract

RIZ1 is an estrogen receptor (ER) coactivator but is also a histone lysine methyltransferase that methylates lysine 9 of histone H3, an activity known to repress transcription. We show here that target organs of mice deficient in RIZ1 exhibit decreased response to female sex hormones. RIZ1 interacted with SRC1 and p300, suggesting that the coactivator function of RIZ1 may be mediated by its interaction with other transcriptional coactivators. In the presence of estrogen, RIZ1 binding to estrogen target genes became less direct and followed the binding of ER to DNA and RIZ1 methyltransferase activity on H3-Lys 9 was inhibited, indicating derepression may play a role in estrogen induction of gene transcription. Reducing RIZ1 level correlated with decreased induction of pS2 gene by estrogen in MCF7 cells. The data suggest that a histone methyltransferase is required for optimal estrogen response in female reproductive tissues and that estrogen-bound ER may turn a transcriptional repressor into a coactivator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282304      PMCID: PMC479744          DOI: 10.1128/MCB.24.16.7032-7042.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

Authors:  S L Anzick; J Kononen; R L Walker; D O Azorsa; M M Tanner; X Y Guan; G Sauter; O P Kallioniemi; J M Trent; P S Meltzer
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.

Authors:  A Takeshita; G R Cardona; N Koibuchi; C S Suen; W W Chin
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

Review 3.  Think globally, act locally: the making of a mouse mammary gland.

Authors:  L Hennighausen; G W Robinson
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

4.  Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.

Authors:  H Chen; R J Lin; R L Schiltz; D Chakravarti; A Nash; L Nagy; M L Privalsky; Y Nakatani; R M Evans
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

5.  Regulation of transcription by a protein methyltransferase.

Authors:  D Chen; H Ma; H Hong; S S Koh; S M Huang; B T Schurter; D W Aswad; M R Stallcup
Journal:  Science       Date:  1999-06-25       Impact factor: 47.728

6.  Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.

Authors:  J Xu; Y Qiu; F J DeMayo; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1998-03-20       Impact factor: 47.728

7.  GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.

Authors:  H Hong; K Kohli; M J Garabedian; M R Stallcup
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

8.  Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.

Authors:  N Huang; E vom Baur; J M Garnier; T Lerouge; J L Vonesch; Y Lutz; P Chambon; R Losson
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression.

Authors:  S Huang; G Shao; L Liu
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

10.  Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism.

Authors:  L I McKay; J A Cidlowski
Journal:  Mol Endocrinol       Date:  1998-01
View more
  26 in total

1.  Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Authors:  Ivan Garcia-Bassets; Young-Soo Kwon; Francesca Telese; Gratien G Prefontaine; Kasey R Hutt; Christine S Cheng; Bong-Gun Ju; Kenneth A Ohgi; Jianxun Wang; Laure Escoubet-Lozach; David W Rose; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

2.  Structural and functional characterization of the acidic region from the RIZ tumor suppressor.

Authors:  Yizhi Sun; Jessica M Stine; Daniel Z Atwater; Ayesha Sharmin; J B Alexander Ross; Klára Briknarová
Journal:  Biochemistry       Date:  2015-02-02       Impact factor: 3.162

Review 3.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

Review 4.  The Epigenetics of Normal Pregnancy.

Authors:  Jonathan D Best; Nessa Carey
Journal:  Obstet Med       Date:  2013-03-01

5.  Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells.

Authors:  Fei Zhao; Yan Chen; Ling-lan Zeng; Rui Li; Rong Zeng; Lu Wen; Yuan Liu; Chun Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

Review 6.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

7.  Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome.

Authors:  Matthew Dapas; Ryan Sisk; Richard S Legro; Margrit Urbanek; Andrea Dunaif; M Geoffrey Hayes
Journal:  J Clin Endocrinol Metab       Date:  2019-04-30       Impact factor: 5.958

8.  PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells.

Authors:  Christopher A Davis; Michael Haberland; Michael A Arnold; Lillian B Sutherland; Oliver G McDonald; James A Richardson; Geoffrey Childs; Stephen Harris; Gary K Owens; Eric N Olson
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 9.  Comprehensive Catalog of Currently Documented Histone Modifications.

Authors:  Yingming Zhao; Benjamin A Garcia
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-01       Impact factor: 10.005

10.  RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.

Authors:  Ashakumary Lakshmikuttyamma; Naoto Takahashi; Elodie Pastural; Emina Torlakovic; Hesham M Amin; Guillermo Garcia-Manero; Michael Voralia; Magdalena Czader; John F DeCoteau; C Ronald Geyer
Journal:  J Hematol Oncol       Date:  2009-07-14       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.